Genelux GNLX
NASDAQ GNLX
$2.72 -0.02 (-0.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genelux (GNLX) Net Equity Issued and Repurchased (2023 - 2026)

Genelux (GNLX) posted quarterly Net Equity Issued and Repurchased of $18.5 million for Q1 2026, up 93.92% year-over-year from $9.6 million in Q1 2025, and up 93.92% quarter-over-quarter from $9.6 million in Q1 2025.

Genelux (GNLX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends

Genelux's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $18.5 million for Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased rose 93.92% year-over-year to $18.5 million; the TTM figure through Mar 2026 stood at $18.5 million (up 93.61% YoY), while the FY2025 annual figure was $9.6 million, down 65.5% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2026 stood at $18.5 million, up from $9.6 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $18.5 million in Q1 2026, with the low at $15000.0 in Q4 2024.
  • The 4-year median for Net Equity Issued and Repurchased is $8.3 million (2023), against an average of $8.9 million.
  • Peak annual rise in Net Equity Issued and Repurchased reached 93.92% in 2026, while the deepest fall reached 93.92% in 2026.
  • Genelux's Net Equity Issued and Repurchased stood at $3.5 million in 2023, then slumped by 99.57% to $15000.0 in 2024, then soared by 63586.67% to $9.6 million in 2025, then jumped by 93.92% to $18.5 million in 2026.
  • Business Quant data shows GNLX's Net Equity Issued and Repurchased at $18.5 million in Q1 2026, $9.6 million in Q1 2025, and $15000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Genelux 119.87 Mn 119.87 Mn - 18.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.53 Mn
Mar 31, 2026 18.53 Mn
Mar 31, 2025 9.55 Mn
Mar 31, 2025 9.55 Mn
Dec 31, 2024 15,000.00
Dec 31, 2024 15,000.00
Sep 30, 2023 3.50 Mn
Sep 30, 2023 3.50 Mn
Jun 30, 2023 7.14 Mn
Jun 30, 2023 7.14 Mn
Mar 31, 2023 14.50 Mn
Mar 31, 2023 14.50 Mn